“ We are trying to overcome the idea that robotic systems are difficult to adopt with a steep learning curve; they can improve the clinical outcomes of… ”
In Conversation
“ We are calling strongly for a greater role in ensuring that the right treatments are approved, the ones that matter most to patients. The only way… ”
“ The main differentiating factor for Abdi Ibrahim among Turkish companies is our willingness to invest in, and collaborate with, international players ”
“ We are close to having the technological capacity to develop all types of biosimilar products, even some novel ones ”
“ The medical infrastructure in Turkey is substantial with many large hospitals. However, for clinical trials, we need more dedicated places to conduct clinical trials, an institutional… ”
“ Almost 50 percent of clinical trials in the region last year were led by biotechs and by 2025, biotech-led clinical trials will far exceed those led… ”
“ The Turkish authorities continue to be content with the current [pricing] system because it has been sustained until today. The question the industry is asking itself… ”
“ Putting the childhood cancer agenda under the spotlight is especially relevant today, as the world’s focus has shifted almost exclusively to COVID. We must continue to… ”
“ I always come back to the question of how we help as many patients as possible access the healthcare solutions they need. Within this push, collaboration… ”
“ The objective [for Turkey] now should be to implement policies in areas like rare diseases so that we can expedite access to innovative medicines for diseases… ”
Ashok Venkitaraman – Director, Cancer Science Institute of Singapore; Distinguished Professor of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS); Director, NUS Center for Cancer Research; Program Director, Disease Intervention Technology Laboratory, Agency for Science, Technology & Research (A*STAR)
“ Looking beyond current advances in personalized or stratified cancer therapy, I think that early intervention – before the disease becomes advanced – will be the future… ”
“ Singapore is often the first market for [Pfizer's] product launches in Emerging Asia, new regulatory strategies to optimize launch timelines, and digital innovations. We act as… ”